Abstract-Free radicals have important roles in pathogenesis of diabetes mellitus. It has been well documented that there is a link between oxidative stress and secondary complications of diabetes. In the present study we determined and evaluated changes in levels of malondialdehyde (MDA) and antioxidant vitamin E in plasma of Sudanese patients with Type 2 Diabetes Mellitus. Total of 200 diabetic patients (90 male, 110 female) with mean age of 55.48±12.14 years were recruited into the study. Control group was composed of 100 healthy volunteers (47 male, 53 female) with mean age of 53.53±11.43 years. In addition to two mentioned parameters, levels of fasting blood glucose, percentage HbA1C levels were determined in diabetic patients and controls.
I. INTRODUCTION
ATIENTS with Non-Insulin Dependent Diabetes Mellitus (NIDDM) have an increased mortality and morbidity compared to non-diabetics due to various associated complications such as neuropathy, nephropathy, cardiovascular disease, etc.Reactive oxygen species (ROS) and particularly free radical induced lipid per oxidative tissue damage have been implicated in the pathogenesis of various diseases (1) including diabetes (2) . Diabetes mellitus is a disorder with late complications including cardiovascular diseases, nephropathy, neuropathy, retinopathy which affects severely the quality of life (3) . Although there are several reports on complications of diabetes, pathopysiology of these complications are still needed to be deciphered (4) . Recent reports indicate that free radicals have important roles in pathogenesis of diabetes and a relationship between oxidative stress and secondary complications of diabetes exists (5, 6 damaging free radicals in Non-insulin dependent diabetes mellitus (NIDDM) patients which may be due to autooxidation of glucose and glycosylated proteins (7, 8, 9, 10) . Subsequently, free radicals change lipid/protein ratio of membranes by affecting poly unsatured fatty acids and lipid peroxidation, causes functional irregularities of several cellular organelles (11, 12) . Lipid peroxides are disintegrated quickly and form reactive carbon compounds. Among these, MDA is an important reactive carbon compound which is used commonly as an indicator of lipid peroxidation (13) .
Since free radical production is increased whereas capacity of antioxidant systems is reduced in diabetes, it has been proposed that diabetic patients may require more antioxidants compared to healthy individuals (12, 14) . Since effects of free radicals in diabetes are now documented, it has been proposed to use antioxidant vitamins to block formation of free radicals and hence prevent development of diabetes (15, 16) . Glutathione is a very important non-enzymatic antioxidant together with antioxidant vitamins. Vitamins A, E and C are among these important nonenzymatic antioxidants (17, 18) . It has been proposed that in diabetic patients several abnormalities related with absorption develop in the absence of antioxidant vitamins (19) . Vitamin E and glutathione are some of the major nonenzymatic antioxidants in the body. Therefore, the idea of using antioxidant vitamin to prohibit development of diabetes as well as its complications and/or to treat diabetic patients is getting more attention than ever (15, 21) . Although there are studies reporting serum or plasma levels of antioxidant vitamins in diabetic patients, results from different groups are rather contradictory. Studies focusing on involvement of vitamin E in diabetic patients are rather limited. Therefore, the present study was designed to determine and evaluate changes in level of antioxidant vitamin E and MDA in Sudanese patients with type 2 diabetes and healthy subjects. Furthermore, we examined possible relationship between HbA1c, vitamin E, and MDA. Mean age of diabetic patient was 54.8±11.4 years and who were free of clinical symptoms of neuropathy, retinopathy. Control group was consisted of 100 healthy volunteers (47 male, 53 female) whose mean age were 53.53±11.48 years. Venous blood samples were withdrawn after an overnight fasting from patients and controls. Fasting blood glucose levels were determined by a commercial kit by using enzymatic method (glucose oxidase / peroxidase) (Biosystem S.A Costa Brava 30, Barcelona-Spain by auto analyzer humalzer 2000 human-German.) Hb A1c percentage level was determined by method based on aboronate affinity chromatography by using NYCOCARD READER II -AXIS-SHIELD Po C AS NO-0504 Oslo, Norway, rapid invitro test for the measurement of glycated hemoglobin (Hb A1c) % in human whole blood. The machine (NYCOCARD READE II) is traceable to the international federation of clinical chemistry (IFCC) reference method for measurement of Hb A1c, and it's measuring range 3-18 % Hb A1c. MDA levels were determined by the method of Karataş et al. (20) by HPLC utilizing a column (250 x 3.9 ID) packed with Tecopak C18 reversed-phase material (10 mm particle size), were performed at following optimized experimental conditions: mobile phase is 30 mM KH2PO4 buffer, pH = 4 with H3PO4) and methanol (65%-35% v/v) at 1.5 mL min-1 flow rate and 254 nm wavelength. Determination of vitamin E through the HPLC method a chromatographic measurements were made using a HewlettPackard ( wald born , Germany) model 1050 pump system, water 717 plus Auto sampler (Mil ford, MA, USA) , auvvis detector, SPD -10 AV VP (shimadzu Kyoto, Japan) and an HP-3365 series II chemstation. The analytical Colum used was a tracer spherisorb OD52 C18 (250 x 4.6 mm 1.D, 5µm particle size) protected with a guard cartridge (tracer, C18, 5µm).The frozen specimens preserved with metaphosphoric acid (5%) were thawed to around 22 ºC in water bath, protected from light, and then mixed. Statistical analysis was carried out using SPSS for Windows, Ver.10.5 (SPSS Inc. Chicago, IL, USA). The data obtained are expressed as mean values ± S.D. Student's t-test and Pearson test was used to correlations determine whether differences between the means were significant, with p<0.05 taken as the significance level.
II. MATERIAL AND METHODS

Total
III. RESULT
Demographic features of diabetic patients and controls are summarized in Table 1 . MDA and vitamin E are given in Table 2 . Fasting blood glucose and HbA1C% are given in table 3. Table 2 . Shows a highly significant difference between the means of plasma MDA of the test group (n=200) and the control group (n=100).Mean± SD: (4.47±5.29) versus (1.93±0.41) n mol/l, (p=0.00), and shows a significant difference between the means of plasma vitamin E of the test group (n=200) and the control group (n=100).Mean± SD: (5.28±1.51) versus (7.08±2.54) µg/ml, respectively, (p=0.01). Table 3 . Shows a significant difference between the means of plasma levels of fasting plasma glucose of the test group (n=200) and the control group (n=100).Mean± SD: (191.01±58.52) versus (94.74±10.81) mg/dl, (p=0.00), respectively, and shows a significant difference between the means of blood levels of hemoglobin HbA1c % of the test group (n=200) and the control group (n=100)Mean± SD: (9.18±2.19) versus (5.17±0.48) %, (p=0.03) respectively. (21) reported that there was an increase in lipid peroxidation levels whereas vitamin E levels were decreased in patients with Type 2 diabetes mellitus compared to controls. Changes in oxidant and antioxidant systems are related with duration of disease and become more important as complications develop. Findings of several studies demonstrated that overproduction of peroxides along with emaciation of antioxidant defense systems cause oxidative damage and these events in type 2 diabetic patients are observed earlier before diabetic complications develop (23) . Jorge et al. (24) reported that a minor oxidative stress was observed in female with type 2 diabetic patients after α-tocopherols treatment interfered from the reduced level of erythrocyte MDA and the increase total antioxidant status. On the other hand no beneficial change was observed in the levels of serum MDA. Results of vitamin E levels in blood, plasma and serum levels of patients with type 2 diabetes mellitus are contradictory. Several groups reported that there are increases in vitamin E levels of the test group compared to controls (15, (25) (26) . On the other hand, some reports indicate that no significant changes occur (27, 28) . In addition, several studies documented that vitamin E levels in blood, plasma and serum were decreased in type 2 diabetic patients (16, 21, 23, (29) (30) . In the present study we also observed the latest trend. Table 2 , this may be due to depressed antioxidant vitamins levels or it may be due to increased demand of vitamin E to relive increased oxidative stress observed in these patients. There are several reports indicating increased MDA levels in patients with type 2 diabetes (22, (31) (32) or unchanged [24] . Results of present study support these findings (22, (31) (32) , this could be due to oxidative events caused by metabolic stress, or exposure to prolonged periods of hyperglycemia, which causes non enzymatic glycation of plasma proteins (binding of glucose to protein molecules), or may be due to poor diabetic control which may enhance lipid per oxidation and diminishes the body's antioxidant capacity, or may be due to mobilization of lipids for a further use as an energy sources rather than glucose.
